Table 2 Demographic and clinicopathologic characteristics of 38 study subjects who underwent radical prostatectomy
| Â | Cancer |
|---|---|
| Â | N = 38 |
Median Age (range, y) | 63 (47-72) |
Race | Â |
   White | 24 (63) |
   African American | 12 (32) |
   Other | 2 (5) |
Median Serum PSA (ng/ml) | 9.2 ± 4.7 |
Pathologic Stage | Â |
pT2 | 31 (82%) |
pT3a | 3 (8%) |
pT3b | 4 (10%) |
N0 | 36 (95%) |
N1 | 2 (5%) |
Gleason Score | Â |
6 | 19 (50%) |
7 | 13 (34%) |
>7 | 6 (16%) |